AVB patients with PVT were more likely to be female with HBV-related cirrhosis and had more advanced liver disease ie: ascites, higher CTP score, higher AST, and more likely to have HCC ( 67% vs 17%, p 10: 63% vs 44%, p=0.013 )
Some Anthem Blue Cross Blue Shield plans in Michigan may cover FDA-approved GLP-1 medications such as semaglutide (Wegovy) and tirzepatide (Zepbound), typically requiring prior authorization and meeting clinical BMI criteria
It aids in contouring the body, and sculpting it into the desired shape, reducing appearance of orange skin (aka cellulite)
There are other forms of bias in these datasets including channeling (e.g., the prescribing pattern depends on a patient characteristic (particularly diabetes or obesity) that is a PDAC risk factor), detection (e.g., overreporting due to additional testing to rule out a suspected adverse event (e.g., imaging triggered by pancreas enzyme elevations)), and Weber effect (initial increase in event reporting shortly after drug launch) 49